JP2010539895A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010539895A5 JP2010539895A5 JP2010525439A JP2010525439A JP2010539895A5 JP 2010539895 A5 JP2010539895 A5 JP 2010539895A5 JP 2010525439 A JP2010525439 A JP 2010525439A JP 2010525439 A JP2010525439 A JP 2010525439A JP 2010539895 A5 JP2010539895 A5 JP 2010539895A5
- Authority
- JP
- Japan
- Prior art keywords
- snorna
- nucleic acid
- sequence
- modified
- genbank accession
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108020003224 Small Nucleolar RNA Proteins 0.000 claims 77
- 102000042773 Small Nucleolar RNA Human genes 0.000 claims 77
- 150000007523 nucleic acids Chemical class 0.000 claims 49
- 102000039446 nucleic acids Human genes 0.000 claims 40
- 108020004707 nucleic acids Proteins 0.000 claims 40
- 210000004027 cell Anatomy 0.000 claims 17
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 15
- 241000616464 Wallacemonas collosoma Species 0.000 claims 15
- 238000000034 method Methods 0.000 claims 15
- 230000000295 complement effect Effects 0.000 claims 9
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims 7
- 108090000623 proteins and genes Proteins 0.000 claims 7
- 102000004169 proteins and genes Human genes 0.000 claims 6
- 239000013598 vector Substances 0.000 claims 6
- 241000223105 Trypanosoma brucei Species 0.000 claims 5
- 238000010367 cloning Methods 0.000 claims 4
- 239000002773 nucleotide Substances 0.000 claims 4
- 125000003729 nucleotide group Chemical group 0.000 claims 4
- 238000012545 processing Methods 0.000 claims 4
- 230000001105 regulatory effect Effects 0.000 claims 4
- 108020004999 messenger RNA Proteins 0.000 claims 3
- 101100444344 Caenorhabditis elegans eat-17 gene Proteins 0.000 claims 2
- 108091026890 Coding region Proteins 0.000 claims 2
- 108091026898 Leader sequence (mRNA) Proteins 0.000 claims 2
- 241000222702 Leishmania tarentolae Species 0.000 claims 2
- 108091036066 Three prime untranslated region Proteins 0.000 claims 2
- 108020004566 Transfer RNA Proteins 0.000 claims 2
- 239000012634 fragment Substances 0.000 claims 2
- 108091070501 miRNA Proteins 0.000 claims 2
- 239000002679 microRNA Substances 0.000 claims 2
- 238000012986 modification Methods 0.000 claims 2
- 230000004048 modification Effects 0.000 claims 2
- 238000013518 transcription Methods 0.000 claims 2
- 230000035897 transcription Effects 0.000 claims 2
- 230000003612 virological effect Effects 0.000 claims 2
- 240000005528 Arctium lappa Species 0.000 claims 1
- 241000196324 Embryophyta Species 0.000 claims 1
- 241000238631 Hexapoda Species 0.000 claims 1
- 102000008300 Mutant Proteins Human genes 0.000 claims 1
- 108010021466 Mutant Proteins Proteins 0.000 claims 1
- 241000223104 Trypanosoma Species 0.000 claims 1
- 230000001580 bacterial effect Effects 0.000 claims 1
- 230000001413 cellular effect Effects 0.000 claims 1
- 230000001276 controlling effect Effects 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 238000007877 drug screening Methods 0.000 claims 1
- 210000003527 eukaryotic cell Anatomy 0.000 claims 1
- 238000009396 hybridization Methods 0.000 claims 1
- 230000010354 integration Effects 0.000 claims 1
- 210000004962 mammalian cell Anatomy 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000003550 marker Substances 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 230000037361 pathway Effects 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000013600 plasmid vector Substances 0.000 claims 1
- 230000006798 recombination Effects 0.000 claims 1
- 238000005215 recombination Methods 0.000 claims 1
- 238000011160 research Methods 0.000 claims 1
- 239000013603 viral vector Substances 0.000 claims 1
- 210000005253 yeast cell Anatomy 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0718542.4 | 2007-09-22 | ||
| GBGB0718542.4A GB0718542D0 (en) | 2007-09-22 | 2007-09-22 | Targeted modulation of gene expression |
| PCT/GB2008/003211 WO2009037490A1 (en) | 2007-09-22 | 2008-09-22 | Targeted modulation of gene expression |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010539895A JP2010539895A (ja) | 2010-12-24 |
| JP2010539895A5 true JP2010539895A5 (OSRAM) | 2011-11-10 |
| JP5756631B2 JP5756631B2 (ja) | 2015-07-29 |
Family
ID=38670367
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010525439A Expired - Fee Related JP5756631B2 (ja) | 2007-09-22 | 2008-09-22 | 遺伝子発現の標的調節 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20110212058A1 (OSRAM) |
| EP (1) | EP2205739B1 (OSRAM) |
| JP (1) | JP5756631B2 (OSRAM) |
| CN (1) | CN101868543A (OSRAM) |
| GB (1) | GB0718542D0 (OSRAM) |
| WO (1) | WO2009037490A1 (OSRAM) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013022092A1 (ja) * | 2011-08-11 | 2013-02-14 | 学校法人新潟科学技術学園新潟薬科大学 | ヒト血液がん細胞のアポトーシスを誘導するヘプタマー型スモールガイド核酸 |
| GB201117482D0 (en) | 2011-10-11 | 2011-11-23 | Univ Dundee | Targetiing of miRNA precursors |
| WO2016048833A2 (en) | 2014-09-26 | 2016-03-31 | Janssen Pharmaceutica Nv | Use of fgfr mutant gene panels in identifying cancer patients that will be responsive to treatment with an fgfr inhibitor |
| CN108473527A (zh) | 2015-12-09 | 2018-08-31 | 切除生物治疗公司 | 用于消除免疫抑制疗法期间jc病毒激活和pml(进行性多灶性白质脑病)风险的基因编辑方法和组合物 |
| EP3720508A4 (en) * | 2017-12-08 | 2021-09-01 | University of Connecticut | COMPOSITIONS AND METHODS FOR TREATMENT OF GENOMIC FOOTPRINT DISORDERS |
| CN112020557B (zh) * | 2018-03-27 | 2025-02-11 | 罗切斯特大学 | 用于假尿苷化的核酸分子 |
| WO2024102659A1 (en) * | 2022-11-08 | 2024-05-16 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Directed acetylation of mrna through engineered snorna adapters |
| CN116694759B (zh) * | 2023-02-17 | 2023-12-15 | 中国人民解放军军事科学院军事医学研究院 | Scarna12基因调节细胞增殖与存活中的应用 |
| CN116525001A (zh) * | 2023-04-27 | 2023-08-01 | 西安交通大学 | 一种基于深度学习的rna修饰位点预测模型的构建方法 |
-
2007
- 2007-09-22 GB GBGB0718542.4A patent/GB0718542D0/en not_active Ceased
-
2008
- 2008-09-22 WO PCT/GB2008/003211 patent/WO2009037490A1/en not_active Ceased
- 2008-09-22 JP JP2010525439A patent/JP5756631B2/ja not_active Expired - Fee Related
- 2008-09-22 US US12/679,208 patent/US20110212058A1/en not_active Abandoned
- 2008-09-22 EP EP08806365.6A patent/EP2205739B1/en not_active Not-in-force
- 2008-09-22 CN CN200880117264A patent/CN101868543A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010539895A5 (OSRAM) | ||
| KR101785847B1 (ko) | 선형 이중가닥 ＤＮＡ를 활용한 ＣＲＩＳＰＲ／Ｃａｓ９ 시스템을 이용한 표적 유전체 교정 | |
| Luff et al. | An inverted repeat triggers cytosine methylation of identical sequences in Arabidopsis | |
| Niksic et al. | Functional analysis of cis-acting elements regulating the alternative splicing of human CFTR exon 9 | |
| JP2022526455A (ja) | Ｒｎａを編集する方法および組成物 | |
| AU2017242794A1 (en) | Novel minimal UTR sequences | |
| Parekh-Olmedo et al. | Targeted nucleotide exchange in Saccharomyces cerevisiae directed by short oligonucleotides containing locked nucleic acids | |
| US20210054370A1 (en) | Methods and compositions for treating angelman syndrome | |
| JP2022548062A (ja) | 亢進したｄｎａ産生を有する修飾型細菌レトロエレメント | |
| TW202509233A (zh) | 用於治療α-1抗胰蛋白酶缺乏症之組合物及方法 | |
| WO2012049665A1 (en) | A modified human u1snrna molecule, a gene encoding for the modified human u1snrna molecule, an expression vector including the gene, and the use thereof in gene therapy | |
| CN118813703A (zh) | 果蝇高效转录抑制系统 | |
| US20250376701A1 (en) | Crispr-transposon systems and components | |
| CN112458080A (zh) | 一种获得针对lncRNA LOC157273的siRNA钓取方法 | |
| CN112980848B (zh) | 一种水稻糖诱导启动子srn1及其应用 | |
| Jiang et al. | Evolutionarily conserved 12-oxophytodienoate reductase trans-lncRNA pair affects disease resistance in tea (Camellia sinensis) via the jasmonic acid signaling pathway | |
| CN109628447B (zh) | 特异靶向羊友好位点H11的sgRNA及其编码DNA和应用 | |
| CN118581064A (zh) | 核酸修饰酶、包含其的碱基编辑器及其应用 | |
| CN116355068A (zh) | 调控玉米穗行数的dna序列、分子标记及其应用 | |
| JPWO2020067004A1 (ja) | 新規ウイルスベクターおよびその製造方法と使用方法 | |
| WO2023147558A2 (en) | Crispr methods for correcting bag3 gene mutations in vivo | |
| CN110551763B (zh) | CRISPR/SlutCas9基因编辑系统及其应用 | |
| WO2023050158A1 (zh) | 一种实现多碱基编辑的方法 | |
| Khanahmad et al. | A novel single step double positive double negative selection strategy for β-globin gene replacement | |
| de Semir et al. | Suitability of oligonucleotide‐mediated cystic fibrosis gene repair in airway epithelial cells |